Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin

Completed · Not applicable

Conditions studied: Pre-diabetes

In brief

This study was designed to examine changes in capillary blood glucose and venous insulin levels after a 70 gram oral sucrose challenge with and without simultaneous consumption of a dietary supplement containing L-Arabinose and a patented version of chromium (LA-Cr).

Key facts

Study ID

NCT01107431

Run by

Integrative Health Technologies, Inc.

People needed

70

Starts

2008-12-01

Expected to finish

2009-12-01

Last updated by the study team

2011-05-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• All study subjects were required to contact their family physician to ensure they had no medical conditions that would preclude their participation.

You may not qualify if…

• Diabetics, and
• Those not approved by their physicians.

Where it is running

• Integrative Health Technologies — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.